Clinical Trial Update: 3BNC117-LS and 10-1074-LS Plus N-803 (bNAb+N-803) [Phase 1]

View source ↗

Summary

Phase 1 study update investigating the combination of bnAbs 3BNC117-LS and 10-1074-LS with N-803 for HIV infection. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• 10-1074-LS (10-1074-LS)
• 3BNC117-LS (3BNC117-LS)
• N-803

Snippet

Sponsor: Rockefeller University | Conditions: Human Immunodeficiency Virus | Phase 1 | Status: COMPLETED